Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus

https://doi.org/10.1016/0002-9343(92)90574-UGet rights and content

Abstract

objective: To evaluate the effect of ceftriaxone in treating latent syphilis or asymptomatic neurosyphilis in patients infected with the human immunodeficiency virus (HIV).

design: Follow-up study of patients treated at two HIV-based clinics during 16 months from 1989 to 1991.

patients: Patients were those in whom a clinical diagnosis of latent syphilis or asymptomatic neurosyphilis was made, who received all recommended doses of antimicrobial therapy, and who returned for follow-up visits for 6 or more months.

results: Forty-three patients were treated with ceftriaxone, 1 to 2 g daily for 10 to 14 days. Thirteen underwent lumbar puncture before treatment; 7 (58%) had documented neurosyphilis (pleocytosis in 5, elevated protein levels in 6, VDRL reactive in cerebrospinal fluid [CSF] in 7), and 6 had documented latent syphilis (entirely normal CSF). The remaining 30 were said to have presumed latent syphilis. There was no relation between the diagnosis and the selected dosage of ceftriaxone. Response rates were similar in those who had documented neurosyphilis and documented or presumed latent syphilis. Overall, 28 patients (65%) responded to therapy, 5 (12%) were serofast, 9 (21%) had a serologic relapse, and 1 (2%) who experienced progression to symptomatic neurosyphilis was a therapeutic failure. Thirteen patients received benzathine penicillin for presumed latent syphilis; results were similar to those observed after ceftriaxone therapy, with 8 (62%) responders, 1 (8%) serofast, 2 (15%) relapses, and 2 (15%) failures. CD4 cell counts in responders were not different from those who failed to respond.

conclusions: Even in the absence of neurologic symptoms, half of the HIV-infected persons who have serologic evidence of syphilis may have neurosyphilis. Although ceftriaxone achieves high serum and CSF levels, 10 to 14 days of treatment with this drug were associated with a 23% failure rate in HIV-infected patients who had latent syphilis or asymptomatic neurosyphilis. Three doses of benzathine penicillin did not have a significantly higher relapse rate and may provide appropriate therapy, at least for documented latent syphilis in persons co-infected with HIV. Studies comparing ceftriaxone with 10 to 14 doses of procaine penicillin are needed to determine the most cost-effective treatment for asymptomatic neurosyphilis or presumed latent syphilis in this group of patients.

References (53)

  • BT Goh et al.

    Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin 0.6 MU with and without probenecid

    Br J Vener Dis

    (1984)
  • B Romanowski et al.

    Serologic response to treatment of infectious syphilis

    Ann Intern Med

    (1991)
  • Centers for Disease Control

    Primary and secondary syphilis—United States, 1981–1990

    MMWR

    (1991)
  • EC Tramont

    Syphilis in the AIDS era

    N Engl J Med

    (1987)
  • WE Stamm et al.

    The association between genital ulcer disease and acquisition of HIV infection in homosexual men

    JAMA

    (1988)
  • TC Quinn et al.

    Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases

    N Engl J Med

    (1988)
  • EW Hook

    Syphilis and HIV infection

    J Infect Dis

    (1989)
  • DM Musher et al.

    Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment

    Ann Intern Med

    (1990)
  • AM Chesney et al.

    Incidence of Spirochaeta pallida in cerebrospinal fluid during early stage of syphilis

    JAMA

    (1924)
  • JH Stokes

    Modern clinical syphilology: diagnosis-treatment-case study

    (1934)
  • RH Kampmeier

    Essentials of syphilology

    (1943)
  • SA Lukehart et al.

    Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment

    Ann Intern Med

    (1988)
  • JA Mohr et al.

    Neurosyphilis and penicillin levels in cerebrospinal fluid

    JAMA

    (1976)
  • N Polnikorn et al.

    Penicillin concentrations in cerebrospinal fluid after different treatment regimens for syphilis

    Br J Vener Dis

    (1980)
  • A Perdrup et al.

    The profile of neurosyphilis in Denmark

  • HW Jaffe et al.

    Examination of cerebrospinal fluid in patients with syphilis

    Rev Infect Dis

    (1982)
  • RL Harris et al.

    Fever, headache, and hearing loss in a young homosexual man

    Hosp Pract

    (1985)
  • LL Bayne et al.

    Acute syphilitic meningitis: its occurrence after clinical and serologic cure of secondary syphilis with penicillin G

    Arch Neurol

    (1986)
  • DR Johns et al.

    Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus

    N Engl J Med

    (1987)
  • CD Berry et al.

    Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection

    N Engl J Med

    (1987)
  • R Clark et al.

    Neurosyphilis and HIV infection

    South Med J

    (1988)
  • MJ Lanska et al.

    Syphilitic polyradiculopathy in an HIV-positive man

    Neurology

    (1988)
  • CS Kase et al.

    Pontine pure motor hemiparesis due to meningovascular syphilis in human immunodeficiency virus-positive patients [letter]

    Arch Neurol

    (1988)
  • DA Katz et al.

    Neurosyphilis in acquired immunodeficiency syndrome

    Arch Neurol

    (1989)
  • ME Smith et al.

    Otologic manifestations of AIDS: the otosyphilis connection

    Laryngoscope

    (1989)
  • DM Musher

    Syphilis, neurosyphilis, penicillin and AIDS

    J Infect Dis

    (1991)

    • Cited by (0)

    View full text
    Copyright © 1992 Published by Elsevier Inc.